---  
layout: startup_page  
title: "Synnovation Therapeutics"  
id: "synnovationtx.com"  
permalink: "/synnovationtherapeuticssynnovationtx.com01242024/"  
website: "https://www.synnovationtx.com/"  
funding_round: "Series A"  
funding_amount: "$102M"  
investors: "Third Rock Ventures, Nextech, Lilly Asia Ventures, Sirona Capital, Cormorant Asset Management"  
about: "Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized for best-in-class pharmacology against validated disease targets. Their pipeline focuses on precision oncologic targets, aiming to improve patient outcomes by addressing limitations of existing treatments. The company's lead program, SNV1521, is a PARP1 inhibitor currently in Phase I studies."  
markets: "Biotechnology, Oncology, Pharmaceutical, Life Science, Medical"  
hq: "Wilmington, Delaware, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/synnovationtx"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/synnovation-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/484385-41"  

date_display: "24-Jan-2024"  
date: "2024-01-24"

# SEO Optimization  
meta_title: "Synnovation Therapeutics - Series A Funding ($102M)"  
meta_description: "Synnovation Therapeutics, Synnovation Therapeutics is a precision medicine company developing small molecule therapies optimized for best-in-class pharmacology against validate..."  
meta_keywords: "Synnovation Therapeutics, Biotechnology, Oncology, Pharmaceutical, Life Science, Medical, Series A funding"  
canonical_url: "https://startup.projectstartups.com/synnovationtherapeuticssynnovationtx.com01242024/"  
---